Pivotal Decision for Acute Coronary Syndrome Patient with Left Main Coronary Artery Disease, When to Choose PCI over CABG
Abstract
Background: Surgery is acceptable as a standard treatment of Left Main Coronary Artery (LMCA) Disease in a stable angina condition. But, in Acute Coronary Syndrome (ACS) setting, LMCA intervention is a still clinical challenge in many cardiac centers. Percutaneous coronary intervention (PCI) has emerged as a suitable alternative to coronary artery bypass grafting (CABG) for high-risk complex coronary artery disease (CAD) scenario. This study aimed to outline the management of NSTEMI patient include LMCA disease.
Case Report: A 72-year-old male presented with persistent chest pain, with a confirmed NSTEMI. A coronary angiography was done and revealed Three Vessel Disease (TVD) and Left Main (LM) CAD with highly calcified stenosis in the distal LM and Left Anterior Descending (LAD). An early invasive procedure was successfully performed for severely calcified LAD artery and distal LM lesions, using proper selection of several bail-out pre-dilatation difficult attempts such as scoring ballon and rotational atherectomy (RA). We observed the aftercare period, which showed no subsequent ACS events.
Conclusion: Managing ACS patients requires careful consideration and risk assessment before deciding on revascularization procedures, especially in high-risk case such as LMCA disease. PCI can be an effective treatment strategy for this population but require good consideration of patient’s anatomical factors, comorbidities, the availability of appropriate skill and equipment.
Keywords
Full Text:
PDFReferences
Li T, Yuan J. Comparison of CABG and PCI in NSTE-ACS patients with three-vessel coronary artery disease. Eur Heart J. 2021;42(Supplement_1):2021. doi:10.1093/eurheartj/ehab724.1237
Díez-Villanueva P, Méndez CJ, Alfonso F. Non-ST elevation acute coronary syndrome in the elderly. J Geriatr Cardiol. 2020;17(1):9-15. doi:10.11909/j.issn.1671-5411.2020.01.009
Ram E, Sternik L, Klempfner R, et al. Outcomes of different revascularization strategies among patients presenting with acute coronary syndromes without ST elevation. J Thorac Cardiovasc Surg. 2020;160(4):926-935.e6. doi:10.1016/j.jtcvs.2019.08.130
Zwart B, ten Berg JM, van ’t Hof AW, et al. Indications for an early invasive strategy in NSTE-ACS patients. Netherlands Hear J. 2020;28(3):131-135. doi:10.1007/s12471-019-01337-5
Gunn J, Taggart DP. Revascularisation for acute coronary syndromes: PCI or CABG? Heart. 2003;89(9):967-970. doi:10.1136/heart.89.9.967
Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: Executive summary: A report of the American College of Cardiology Foundation/American HeartA sociation Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;124(23):2574-2609. doi:10.1161/CIR.0b013e31823a5596
Collet J-P, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Russ J Cardiol. 2021;26(3). doi:10.15829/1560-4071-2021-4418
Task A, Members F, Byrne RA, et al. 2023 ESC Guidelines for the management of acute coronary syndromes Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology ( ESC ) ( United Kingdom ), ( United Kingdom ),. Published online 2023:1-107.
Kimura K, Kimura T, Ishihara M, et al. JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome. Circ J. 2019;83(5):1085-1196. doi:10.1253/circj.CJ-19-0133
Mihajlović D, Maksimović ŽM, Dojčinović B, Banjac N. Acute Coronary Syndrome ( STEMI , NSTEMI and Unstable Angina Pectoris ) and Risk Factors , Similarities and Differences. 2021;(January). doi:10.5937/scriptamed51-27722
Collet JP, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289-1367. doi:10.1093/eurheartj/ehaa575
Serruys PW, Ono M, Garg S, et al. Percutaneous Coronary Revascularization: JACC Historical Breakthroughs in Perspective. J Am Coll Cardiol. 2021;78(4):384-407. doi:https://doi.org/10.1016/j.jacc.2021.05.024
Smith JN, Negrelli JM, Manek MB, Hawes EM, Viera AJ. Diagnosis and management of acute coronary syndrome: an evidence-based update. J Am Board Fam Med. 2015;28(2):283-293. doi:10.3122/jabfm.2015.02.140189
Hawkins BM, Fitzgerald-Mckeon LM, Yeh RW. High-risk percutaneous coronary intervention in the era of public reporting: Clinical and ethical considerations in the care of an elderly patient with critical left main disease and shock. Circulation. 2014;129(2):258-265. doi:10.1161/CIRCULATIONAHA.113.004604
Neumann F-J, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87-165. doi:10.1093/eurheartj/ehy394
Feldman D, Beerkens F, Nicolas J, et al. Defining Key Features of Complex Coronary Lesions: An Evidence Based Review of Clinical Practice. Part II: Chronic Total Occlusions, Graft Interventions, In-Stent Restenosis, and Antithrombotic Strategies. Rev Cardiovasc Med. 2022;23(6). doi:10.31083/j.rcm2306209
Li T, Jiang L, Xu L, et al. Interaction Between Treatment and Age or Sex in Non-ST-Segment Elevation Acute Coronary Disease and Three-Vessel Disease. Front Cardiovasc Med. 2022;9. doi:10.3389/fcvm.2022.879834
Chang M, Lee CW, Ahn JM, et al. Comparison of Outcome of Coronary Artery Bypass Grafting Versus Drug-Eluting Stent Implantation for Non–ST-Elevation Acute Coronary Syndrome. Am J Cardiol. 2017;120(3):380-386. doi:10.1016/j.amjcard.2017.04.038
Head SJ, Milojevic M, Daemen J, et al. Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data. Lancet. 2018;391(10124):939-948. doi:10.1016/S0140-6736(18)30423-9
Barssoum K, Kumar A, Rai D, et al. Meta-analysis Comparing Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting for Non-ST Elevation Acute Coronary Syndrome in Patients With Multivessel or Left Main Disease. Curr Probl Cardiol. 2022;47(10):101306. doi:https://doi.org/10.1016/j.cpcardiol.2022.101306
Gaba P, Christiansen EH, Nielsen PH, et al. Percutaneous Coronary Intervention vs Coronary Artery Bypass Graft Surgery for Left Main Disease in Patients With and Without Acute Coronary Syndromes: A Pooled Analysis of 4 Randomized Clinical Trials. JAMA Cardiol. 2023;8(7):631-639. doi:10.1001/jamacardio.2023.1177
Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2011;124(23):2610-2642. doi:10.1161/CIR.0b013e31823b5fee
DOI: https://doi.org/10.21776/ub/hsj.2024.005.03.12
Refbacks
- There are currently no refbacks.
Copyright (c) 2024 Danti Utami Setyowati, Mohammad Saifur Rohman, Indra Prasetya
This work is licensed under a Creative Commons Attribution 4.0 International License.